OCI

456040KOSPI

50.0 / 100

Reference Date: 2026-09-08

Financial Score20.5 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure9.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 5.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

OCI produces a wide range of chemical products, including inorganic, organic, and carbon materials, and is expanding into semiconductor and secondary battery material sectors. In 2024, the company reported consolidated sales of 22.15 trillion KRW, with domestic sales at 13.61 trillion KRW and overseas sales at 969.1 billion KRW. Key products include polysilicon for semiconductors and carbon black.

Number of Employees

3,360people

Average Salary

98.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.63Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

-5.69Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

32.71Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲31.3% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼3.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 1.2% (declining, 2yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
[K바이오 M&A 진단]中 바이오텍 쇼핑하는 빅파마…K바이오 M&A 빅...
기사는 글로벌 빅파마의 M&A 동향을 다루고 있으나, 특정 OCI 주식에 직접적인 영향은 언급되지 않았습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 81,800Won52-week high 150,00052-week low 53,700

1-month return4.0Point

1m +5.68% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 1Neutral 3Negative 1

Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-28
Negative지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항2026-08-13
Neutral반기보고서 (2026.06)2026-08-13
Neutral신탁계약해지결과보고서2026-08-11
Positive주요사항보고서(자기주식취득신탁계약해지결정)2026-08-10